Olaparib (Compound)

Synonyms:Olaparib, 763113-22-0, AZD2281, Lynparza, KU-0059436, AZD-2281, AZD 2281, 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine, OLAPARIB cpd, Olaparib (AZD-2281), 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one, KU-59436, Olaparib (AZD2281, Ku-0059436), Olaparib [USAN:INN], UNII-WOH1JD9AR8, WOH1JD9AR8, 4-[[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one, C24H23FN4O3, AZ2281, MFCD13185161, NSC-747856, CHEBI:83766, 4-(3-{[4-(Cyclopropylcarbonyl)piperazin-1-Yl]carbonyl}-4-Fluorobenzyl)phthalazin-1(2h)-One, 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one, AZ-2281, KEYLYNK-010 COMPONENT OLAPARIB, KU59436, OLAPARIB COMPONENT OF KEYLYNK-010, Olaparib [INN], 4-[(3-{[4-(Cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]phthalazin-1(2H)-one, Olaparib (AZD2281; Ku-0059436), Olaparib (AZD2281), Olaparibum, AZD221, 4-[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorobenzyl]phthalazin-1(2H)-one, Olaparib- Bio-X, Lynparza (TN), 09L, 4-((3-{(4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl}-4-fluorophenyl)methyl)phthalazin-1(2H)-one, KU 59436, OLAPARIB [USAN], OLAPARIB [JAN], KU0059436, OLAPARIB [MI], OLAPARIB [VANDF], Olaparib - AZD2281, OLAPARIB [MART.], OLAPARIB [WHO-DD], AZD-2281 (Olaparib), Olaparib (JAN/USAN/INN), MLS006010185, SCHEMBL426568, OLAPARIB [ORANGE BOOK], CHEMBL521686, GTPL7519, BDBM27566, DTXSID60917988, EX-A002, BCPP000360, HMS3295I09, HMS3426C03, HMS3654G13, HMS3746K07, HMS3870H03, AMY10295, BCP01872, 763113-22-0, Lynparza,, NSC747856, NSC753686, s1060, AKOS005145764, AC-7939, BCP9000363, CCG-264799, CS-0075, DB09074, EX-7210, NSC 747856, NSC-753686, SB14617, SS-4573, AZD2281,Olaparib, KU-0059436, NCGC00238451-01, NCGC00238451-02, NCGC00238451-08, NCGC00238451-09, NCGC00238451-11, 4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one, 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone, 4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one, BO164169, HY-10162, SMR004701291, SY040527, Olaparib(AZD2281,KuDOSKU-0059436), A9666, BB 0260909, FT-0651458, SW218142-2, EC-000.2324, D09730, EN300-7542225, J-503540, Q7083106, BRD-K02113016-001-08-9, BRD-K02113016-001-09-7, Z2227698469, 1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazine, 4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one, (2H)-Phthalazinone, 4-((3-((4-(cyclopropylcarbonyl)-1-piperazinyl)carbonyl)-4-fluorophenyl)methyl)-, 1(2H)-PHTHALAZINONE, 4-((3-((4-(CYCLOPROPYLCARBONYL)-1-PIPERAZINYL)CARBONYL)-4-FLUOROPHENYL)METHYL)-, 1021843-02-6, 4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one, PIPERAZINE, 1-(CYCLOPROPYLCARBONYL)-4-(5-((3,4-DIHYDRO-4-OXO-1-PHTHALAZINYL)METHYL)-2-FLUOROBENZOYL)-

Id:23725625

Description:nan